Nathan Kung

Research Assistant

Biography

-

Nathan Kung is in his fourth year of a five-year joint MD-MBA program at the Geisel School of Medicine and Tuck School of Business.

Nathan brings passion and insight into digital health and mental healthcare from work experiences in Lyra Health, where he worked in clinical product developing their centralized medication management platform, and Genoa Telepsychiatry. Nathan is also a published author of several studies investigating the role of smartphone apps as an intervention for smoking cessation during his time as a research fellow for the Center for Technology and Behavioral Health at Dartmouth. Currently in his full-time business school year, Nathan has focused on building early-stage companies as an advisor at Mandala, a pre-seed emotional well-being platform for people of color, and as a fellow at Borealis Ventures. Nathan completed his Bachelor of Arts in Neuroscience at Columbia University in 2016. Outside of school, Nathan enjoys playing basketball and music, recently picking up the drums, and grew up in Bethesda, Maryland.

Education

  • Doctor of Medicine - MD Geisel School of Medicine at Dartmouth (2018)
  • Bachelor of Arts (B.A.) Columbia University in the City of New York (2012 — 2016)

Companies

  • MBA Student The Tuck School of Business at Dartmouth (2021)
  • MD Candidate Geisel School of Medicine at Dartmouth (2018)
  • Certified Global Leadership Organization Counselor Global Leadership Organization (2015)
  • Research Assistant Center for Technology and Behavioral Health (2019 — 2021)
  • Clinical Product Intern Lyra Health (2019 — 2019)
  • Executive Board Member Global Leadership Organization (2017 — 2018)
  • Research Assistant Tisch MS Research Center of New York (2016 — 2018)
  • Marketing and Business Development Intern InSight Telepsychiatry (2016 — 2016)
  • Business Development Intern Genoa, a QoL Healthcare Company (2015 — 2016)

Read about executive education

Other experts

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.